Verastem To Present At Rodman & Renshaw 17th Annual Global Investment Conference

BOSTON--(BUSINESS WIRE)--Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will present at the Rodman and Renshaw 17th Annual Global Investment Conference on Thursday, September 10 at 3:50 p.m. ET at the St. Regis Hotel in New York City.

Help employers find you! Check out all the jobs and post your resume.